News &
Events
Corporate
Overview
Science &
Technology
R & D
Pipeline
Partnering
Investor
Relations
Media
Careers &
Jobs
|
Cytos Biotechnology is committed to providing the media with comprehensive and accurate information. This section offers key resources for journalists, editors and other media professionals.
|
|
 |
|
| Annual Report | |
| Cytos Press Releases | |
| Corporate Information | |
| R & D Pipeline | |
| Product Fact Sheets | |
|
|
| NIC002 a therapeutic vaccine in phase II development for the treatment of nicotine addiction. |
|
| CYT006-AngQb a therapeutic vaccine in phase II development for the treatment of hypertension. |
|
| CYT003-QbG10 a novel immunotherapy in phase II development for the treatment of allergy and asthma. |
|
Technology Fact Sheets |
|
|
|
| The Immunodrug™ Technology a versatile vaccines’ platform for the development of novel therapeutic vaccines. |
|
| GMP Production the fast-track to product development. |